Table 1

Demographics of 103 patients with diffuse large B-cell lymphoma (DLBCL)

	n	%	Low to moderate	Strong	p Value
Sex
Male	55	53.4
Female	48	46.6
Lymphoma subtype
DLBCL	88	85.4
T-cell-rich B-cell lymphoma	14	13.6
Primary mediastinal B-cell lymphoma	1	1.0%
B-symptoms
None	57	55.3	28	29
Yes	43	41.7	8	35
Missing	3	2.9			0.002*
Age
<60 years	36	35.0	15	21
>60 years	67	65.0	21	46	0.386*
LD levels
Normal	42	40.8	18	24
Elevated	60	58.3	17	43
Missing	1	1.0			0.143*
Stage
I–II	47	45.6	17	30
III–IV	56	54.4	19	37	0.838*
WHO performance status
0–1	80	77.7	30	50
>1	21	20.4	5	16
Missing	2	1.9			0.308*
Extranodal effusion
None	76	69.1	26	46
≥1	34	30.9	10	21	0.823*
IPI
1–2	58	56.3	21	37
3–5	41	39.8	14	27
Missing	4	3.9			1.000*

Median age was 68.00 years, range 21−90. Known risk markers of DLBCL are compared with expression of cytoplasmic peroxiredoxin VI.
*Fisher's exact test.
IPI, International Prognostic Index; LD, lactate dehydrogenase.